Showing results (651-660 of 721) with videos related to

Sort By:
Pageof 73
Scandinavian Journal of Medicine & Science in Sports|December 14, 2022
Associations of sedentary time, physical activity, and fitness with muscle glucose uptake in adults with metabolic syndromeTaru Garthwaite, Tanja Sjöros, Saara Laine, et al.
The Journal of Physical Chemistry. A|February 20, 2015
Detection and Identification of the Keto-Hydroperoxide (HOOCH2OCHO) and Other Intermediates during Low-Temperature Oxidation of Dimethyl EtherKai Moshammer, Ahren W Jasper, Denisia M Popolan-Vaida, et al.
Plos One|September 11, 2020
Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve StudyJussi Jaakkola, Samuli Jaakkola, K E Juhani Airaksinen, et al.
Journal of Electrocardiology|May 14, 2022
The prognostic significance of the electrical QRS axis on long-term mortality in acute coronary syndrome patients - The TACOS studyOlli Punkka, Henri-Jussi Kurvinen, Kimmo Koivula, et al.
Science (New York, N.Y.)|April 13, 2013
Direct measurements of conformer-dependent reactivity of the Criegee intermediate CH3CHOOCraig A Taatjes, Oliver Welz, Arkke J Eskola, et al.
Atherosclerosis|June 24, 2014
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) studyAnna Lautamäki, K E Juhani Airaksinen, Tuomas Kiviniemi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2024
Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union's Regulation on Health Technology Assessment for VaccinesNathalie Largeron, Paolo D'Agostino, Ruth Chapman, et al.
Scientific Reports|June 12, 2020
Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRIParisa Movahedi, Harri Merisaari, Ileana Montoya Perez, et al.
Lancet (London, England)|November 3, 2009
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesSteven Black, Juhani Eskola, Claire-Anne Siegrist, et al.
Pageof 73